ESC Professional Premium Access

Focus on the pulmonary vascular bed

Event: ESC Congress 2022
Topic: Valvular Heart Disease
Session type: Moderated ePosters
Date: 26 August 2022
Time: 12:15 - 12:40

Congress Session

5 presentations in this session

The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial

Speaker: Doctor P. Clift (Birmingham, GB)

Ventricular-arterial coupling predicts outcomes in adults with a systemic right ventricle

Speaker: Doctor G. Pasqualin (Milan, IT)

Inactivation of catalytic and non-catalytic PI3 kinase gamma functions enhances hypoxia-induced pulmonary hypertension in mice

Speaker: Mrs L. Gnatzy-Feik (Cologne, DE)

Investigating monotherapy and combination therapy trends in newly diagnosed patients with pulmonary arterial hypertension among EU3 & UK physicians over the COVID-19 pandemic.

Speaker: Mr D. Chandler (London, GB)

Efficacy and safety of selexipag in real-life in patients with pulmonary arterial hypertension: early results of RAMPHA study

Speaker: Doctor R. Bravo Marques (Marbella, ES)

5 speakers from this session

Doctor Paul Clift

Queen Elizabeth Hospital Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Giulia Pasqualin

IRCCS San Donato Polyclinic, Milan (Italy)
1 follower

Mrs Leoni Gnatzy-Feik

Heart Center at the University of Cologne, Cologne (Germany)
0 follower

Mr Dale Chandler

Ipsos, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Rafael Bravo Marques

Coast of the sun Hospital, Marbella (Spain)
0 follower

This platform is supported by

logo Novo Nordisk